Neurological disorders are defined as disorders that affect the brain, spine and nerves throughout the human body. It is either associated with CNS or PNS or both. Structural, biochemical or electrical abnormalities can cause a wide range of neurological problems which eventually might lead to different types of mild to severe neurological disorders.
Neurological disorders have different causes and symptoms. Most of them start or emerge during the early stage of life or maybe diagnosed at birth. The symptoms of Neurological disorders vary in each disorder. Congenital causes, gene abnormalities, metabolic disorders, prenatal causes, nutritional deficiencies, complications during childbirth, acquired causes, immune disorders, traumatic brain injury, and toxins are some of the causes of Neurological disorders.
Some neurological disorders are:
Amyotrophic lateral sclerosis or ALS
Key treatment methods of Neurological disorders:
Neuroimaging techniques to diagnose
Cognitive therapy treatment
Deep brain stimulation
There are various other methods to treat these lifelong neurological disorders.
Market Analysis: The global neurology market is expected to increase at a compound annual growth rate (CAGR) of 3.5 percent from $33.3 billion in 2019 to $39.4 billion in 2024. Anticholinergic, antiepileptic, antipsychotic, hypnotic & sedative, analgesics, antihypertensive, anticoagulants, and others are the drug types that make up the global neurological diseases treatment market. According to a study, an estimated 5.4 million Americans suffer from Alzheimer's disease, and someone in the United States acquires the condition every 68 seconds.Due to key driving factors such as increasing prevalence of neurological disorders, developing healthcare infrastructure, rising awareness associated with neurological diseases, which is fueling the rate of diagnosis, and mounting accessibility of modern treatments in developing countries such as China, India, and Indonesia, Asia Pacific was identified as the fastest growing region between 2021 and 2029. According to the report, the global market for neurological disease pharmaceuticals was worth US$ 70 billion in 2018 and is expected to grow at a CAGR of 5% from 2019 to 2027.
ALSO READ Neurology Neurosurgery Neuroscience Neuropsychiatry Pain Disorder and Management Central Nervous System Pediatric Neurology Neuro-Oncology and Brain Tumors Neurophysiology Neuroimmunology Neuropathology Neuroimaging Neurodegenerative disease and Neurodegeneration Neurological Disorders Sleep Disorder Stroke Movement Disorders Parkinsons disease Epilepsy Multiple Sclerosis Alzheimers Disease and Dementia Neuromuscular Disease Case studies and Clinical trials Novel Treatment Strategies Speech Disorders Demyelinating Disorders Cerebrovascular Disorders Autoimmune and Inflammatory Disorders Neuropathy Headache and Facial Pain Diagnosis and Screening of Neurological Disorders Neurology Critical Care Neuropharmacology and Neurochemistry Stem Cells and Neuroregeneration Cognitive Neuroscience Motor System Disorders
Neurology Conferences 2022 Europe Seizures Conferences Neurology Conferences 2022 Clinical Neurology Conferences Psychiatry Conferences Alzheimer's Disease Conferences Dementia Conferences Stroke Conferences Headache Conferences Neurology Conferences 2022 Asia Child Psychology Conferences Sleep Disorders Conferences Neurological Disorders Conferences Neuroscience Conferences 2021 Dubai Muscular Dystrophy Conferences